Cell-wall peptidoglycan biosynthesis — Drug Target

All drugs that target Cell-wall peptidoglycan biosynthesis — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Beta-lactam antibiotic

Marketed (3)

• Bicillin C-R · Pfizer Inc. · Beta-lactam antibiotic · Metabolic
  Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.
• Bicillin C-R · Pfizer · Beta-lactam antibiotic
  Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.
• Bicillin C-R · Pfizer · Beta-lactam antibiotic
  Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.